Literature DB >> 19772831

The role of toll-like receptors in rheumatoid arthritis.

Qi-Quan Huang1, Richard M Pope.   

Abstract

An increasing body of data supports the role of the innate immune system in the pathogenesis of rheumatoid arthritis (RA). Toll-like receptors (TLRs) are expressed by cells within the RA joint and various endogenous TLR ligands are present within the inflamed joints of patients with RA. Further, various animal models suggest that TLR signaling is important in the pathogenesis of disease. Overall, the data suggest that activation by endogenous TLR ligands may contribute to the persistent expression of proinflammatory cytokines by macrophages and the joint damage to cartilage and bone that occurs in RA. The data support a potential role for suppression of TLR signaling as a novel therapeutic approach in patients with RA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19772831      PMCID: PMC2913446          DOI: 10.1007/s11926-009-0051-z

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  51 in total

1.  High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine.

Authors:  Noboru Taniguchi; Ko-ichi Kawahara; Kazunori Yone; Teruto Hashiguchi; Munekazu Yamakuchi; Masamichi Goto; Keiichi Inoue; Shingo Yamada; Kosei Ijiri; Shunji Matsunaga; Toshihiro Nakajima; Setsuro Komiya; Ikuro Maruyama
Journal:  Arthritis Rheum       Date:  2003-04

2.  Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein.

Authors:  Jong Sung Park; Daiva Svetkauskaite; Qianbin He; Jae-Yeol Kim; Derek Strassheim; Akitoshi Ishizaka; Edward Abraham
Journal:  J Biol Chem       Date:  2003-12-04       Impact factor: 5.157

3.  Arthritogenic properties of double-stranded (viral) RNA.

Authors:  Fariba Zare; Maria Bokarewa; Nancy Nenonen; Thomas Bergström; Lena Alexopoulou; Richard A Flavell; Andrej Tarkowski
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

4.  Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.

Authors:  Mitsuhiro Iwahashi; Masahiro Yamamura; Tetsushi Aita; Akira Okamoto; Akiko Ueno; Norio Ogawa; Sachiko Akashi; Kensuke Miyake; Paul J Godowski; Hirofumi Makino
Journal:  Arthritis Rheum       Date:  2004-05

5.  Fas ligation on macrophages enhances IL-1R1-Toll-like receptor 4 signaling and promotes chronic inflammation.

Authors:  Yingyu Ma; Hongtao Liu; Hoang Tu-Rapp; Hans-Juergen Thiesen; Saleh M Ibrahim; Shawn M Cole; Richard M Pope
Journal:  Nat Immunol       Date:  2004-03-07       Impact factor: 25.606

6.  Toll-like receptor 2 pathway drives streptococcal cell wall-induced joint inflammation: critical role of myeloid differentiation factor 88.

Authors:  Leo A B Joosten; Marije I Koenders; Ruben L Smeets; Marleen Heuvelmans-Jacobs; Monique M A Helsen; Kiyoshi Takeda; Shizuo Akira; Erik Lubberts; Fons A J van de Loo; Wim B van den Berg
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

7.  Blood cell gene expression profiling in subjects with aggressive periodontitis and chronic arthritis.

Authors:  Lars K Sørensen; Anne Havemose-Poulsen; Søren U Sønder; Klaus Bendtzen; Palle Holmstrup
Journal:  J Periodontol       Date:  2008-03       Impact factor: 6.993

8.  Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling.

Authors:  Diego Kyburz; Janine Rethage; Reinhart Seibl; Roger Lauener; Renate E Gay; Dennis A Carson; Steffen Gay
Journal:  Arthritis Rheum       Date:  2003-03

9.  Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium.

Authors:  Reinhart Seibl; Thomas Birchler; Susanne Loeliger; Johann Peter Hossle; Renate E Gay; Traudl Saurenmann; Beat A Michel; Reinhard A Seger; Steffen Gay; Roger P Lauener
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

10.  Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4.

Authors:  Christian Termeer; Frauke Benedix; Jonathon Sleeman; Christina Fieber; Ursula Voith; Thomas Ahrens; Kensuke Miyake; Marina Freudenberg; Christopher Galanos; Jan Christoph Simon
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

View more
  90 in total

1.  TLR5, a novel and unidentified inflammatory mediator in rheumatoid arthritis that correlates with disease activity score and joint TNF-α levels.

Authors:  Nathan D Chamberlain; Olga M Vila; Michael V Volin; Suncica Volkov; Richard M Pope; William Swedler; Arthur M Mandelin; Shiva Shahrara
Journal:  J Immunol       Date:  2012-06-01       Impact factor: 5.422

Review 2.  Toll-like receptor signaling: a potential link among rheumatoid arthritis, systemic lupus, and atherosclerosis.

Authors:  QiQuan Huang; Richard M Pope
Journal:  J Leukoc Biol       Date:  2010-05-19       Impact factor: 4.962

3.  Glycoprotein 96 perpetuates the persistent inflammation of rheumatoid arthritis.

Authors:  Qi-Quan Huang; Renee E Koessler; Robert Birkett; Andrea Dorfleutner; Harris Perlman; G Kenneth Haines; Christian Stehlik; Christopher V Nicchitta; Richard M Pope
Journal:  Arthritis Rheum       Date:  2012-11

4.  IL-1R/TLR2 through MyD88 Divergently Modulates Osteoclastogenesis through Regulation of Nuclear Factor of Activated T Cells c1 (NFATc1) and B Lymphocyte-induced Maturation Protein-1 (Blimp1).

Authors:  Zhihong Chen; Lingkai Su; Qingan Xu; Jenny Katz; Suzanne M Michalek; Mingwen Fan; Xu Feng; Ping Zhang
Journal:  J Biol Chem       Date:  2015-10-19       Impact factor: 5.157

5.  Promotion of Inflammatory Arthritis by Interferon Regulatory Factor 5 in a Mouse Model.

Authors:  Pierre Duffau; Hanni Menn-Josephy; Carla M Cuda; Salina Dominguez; Tamar R Aprahamian; Amanda A Watkins; Kei Yasuda; Paul Monach; Robert Lafyatis; Lisa M Rice; G Kenneth Haines; Ellen M Gravallese; Rebecca Baum; Christophe Richez; Harris Perlman; Ramon G Bonegio; Ian R Rifkin
Journal:  Arthritis Rheumatol       Date:  2015-12       Impact factor: 10.995

Review 6.  Developing the next generation of monoclonal antibodies for the treatment of rheumatoid arthritis.

Authors:  Jamie Campbell; David Lowe; Matthew A Sleeman
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

7.  Andrographolide suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.

Authors:  Z J Zhai; H W Li; G W Liu; X H Qu; B Tian; W Yan; Z Lin; T T Tang; A Qin; K R Dai
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

8.  Evaluation of tool-like receptor-2 and 4 and interleukin-6 gene expressions in Turkish rheumatoid arthritis patients.

Authors:  Betul Eser; Nilay Sahin
Journal:  Clin Rheumatol       Date:  2016-04-25       Impact factor: 2.980

Review 9.  The role of glycoprotein 96 in the persistent inflammation of rheumatoid arthritis.

Authors:  Qi-Quan Huang; Richard M Pope
Journal:  Arch Biochem Biophys       Date:  2012-12-17       Impact factor: 4.013

10.  TLR2 deletion promotes arthritis through reduction of IL-10.

Authors:  Qi-Quan Huang; Renee E Koessler; Robert Birkett; Harris Perlman; Lianping Xing; Richard M Pope
Journal:  J Leukoc Biol       Date:  2013-02-27       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.